Search clinical trials for: Ivonescimab

Total 37 results

M.D. Anderson Cancer Center
Summit Therapeutics

Recruiting

Phase 2 Study of Ivonescimab in Patients With Cutaneous Squamous Cell Carcinoma

Cutaneous Squamous Cell Carcinoma

United States
M.D. Anderson Cancer Center
Summit Therapeutics Sub, Inc

Recruiting

A Phase I/II Study of IVONESCIMAB in Recurrent Glioblastoma

Glioblastoma

United States
Memorial Sloan Kettering Cancer Center
Summit Therapeutics Sub, Inc

Recruiting

A Study of Ivonescimab in People With Endometrial and Cervical Cancers

Cervical Cancer | Endometrial Cancer

United States
Glenn J. Hanna
Summit Therapeutics

Recruiting

A Phase 2 Trial of Ivonescimab for Patients With Advanced, Metastatic Salivary Gland Cancers (I-MAC)

Adenoid Cystic Carcinoma | Salivary Gland Cancer | Advanced Salivary Gland Carcinoma | Metastatic Salivary Gland Cancer

United States
Intergroupe Francophone de Cancerologie Thoracique
Summit Therapeutics

Not yet recruiting

Evaluating Ivonescimab As a Potential Treatment for Pleural Mesothelioma Patients Whose Cancer Has Returned After Previous Immunotherapy and Chemotherapy (Bi-MAPS)

Pleural Mesotheliomas

France
Tianjin Medical University Cancer Institute and...

Not yet recruiting

Neoadjuvant Ivonescimab and Chemotherapy in Resectable Esophageal Cancer

Esophageal Squamour Cell Cancer

China
Jiangsu Province Nanjing Brain Hospital
Henan Cancer Hospital; Three Gorges Hospital of Chongqing University

Not yet recruiting

Ivonescimab Combined With Chemotherapy for the Treatment of Leptomeningeal Metastases Failed to EGFR-TKIs

NSCLC | Chemotherapy | Leptomeningeal Metastases | EGFR-TKI | AK112
Sun Yat-sen University

Not yet recruiting

Ivonescimab Combined with Chemotherapy As First-line Treatment of Relapsed or Metastatic Thymic Cancer: a Prospective, Single Arm, Phase II Trial (iTHYM)

First-line Treatment | Relapsed or Metastatic Thymic Cancer
UNICANCER
Summit Therapeutics; Cancer Research UK & UCL Cancer Trials Centre; Belgian Group...

Not yet recruiting

Testing Ivonescimab Versus FOLFOX in Advanced Biliary Tract Cancer Patients (SEVILLA)

Biliary Tract Cancer

United Kingdom, France, Belgium
The First Hospital of Jilin University

Recruiting

Multicenter Single-Arm Study of Ivonescimab (AK112) Combined with Chemotherapy in Pretreated Pleural Mesothelioma

Pretreated Pleural Mesothelioma

China
Cancer Institute and Hospital, Chinese Academy...

Recruiting

Ivonescimab Plus Chemotherapy in Patients with Initially Unresectable Colorectal Cancer Liver Metastases

Colorectal Liver Metastases

China
Shandong Cancer Hospital and Institute

Recruiting

Adapted Guided Stereotactic Body Radiotherapy Combined with Chemotherapy and Enhancement of Novel Drug Ivonescimab for Pancreatic Cancer (ASCEND)

Pancreatic Cancer

China
The First Affiliated Hospital of Zhengzhou University

Not yet recruiting

Short-course Radiotherapy Followed by CAPOX and Ivonescimab for Locally Advanced Rectal Cancer

Locally Advanced Rectal Cancer
Hubei Cancer Hospital

Recruiting

SBRT, Chemotherapy, and AK112 Neoadjuvant Therapy for Luminal-type Breast Cancer

Breast Cancer

China
Akeso

Recruiting

An Exploratory, Multi-cohort Phase II Study of Combination Therapy With AK104 and AK112 for Recurrent Ovarian Cancer

Recurrent Ovarian Cancer

China
Fudan University

Recruiting

BrAin Metastasis in TripLe Negateive Breast Cancer: IvoneScimab and Trop2 ADC (BALISTA)

Brain Metastases | Triple-Negative Breast Cancer (TNBC)

China
Akeso
Fudan University Shanghai Cancer Center ( FUSCC )

Not yet recruiting

A Study of mRNA Vaccines AK154 Monotherapy or in Combination With AK104/AK112,and Sequential mFOLFIRINOX in Surgically Resected PDAC

Pancreas Cancer, Duct Cell Adenocarcinoma | Pancreas Cancer

China
The Second Affiliated Hospital of Dalian Medical...
Shengjing Hospital

Not yet recruiting

Irinotecan Liposome(II) Combined with Ivonescimab As Second-line Treatment for Small Cell Lung Cancer : a Prospective, Single-arm, Multicenter Clinical Study

SCLC

China
Lei Liu

Recruiting

A Phase II Study of Neoadjuvant Immunotherapy in Combination With Chemotherapy in Locally Advanced Head and Neck Squamous Cell Carcinoma

Head and Neck Squamous Cell Carcinoma

China
Sun Yat-sen University

Not yet recruiting

Neoadjuvant CAPOX Plus Ivonescimab Versus CAPOX for Locally Advanced Colon Cancer

Colon Cancer
Summit Therapeutics

Recruiting

Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients With High PD-L1 (HARMONi-7)

Non-Small Cell Lung Cancer

United States
Summit Therapeutics

Recruiting

Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients

Non-Small Cell Lung Cancer

United States, France, Spain, Canada, Serbia, Germany, Greece, Ireland, Italy, Mexico, Poland, United Kingdom
Tianjin Medical University Cancer Institute and...

Recruiting

Ivonescimab Combined With HAIC for the Treatment of Unresectable Hepatocellular Carcinoma（uHCC）.

Hepatocellular Carcinoma | Hepatocellular Carcinoma Non-resectable

China
Fudan University
Fujian Cancer Hospital

Not yet recruiting

Phase II Multi-centered Study of Perioperative Ivonescimab Versus Pembrolizumab Combined with Standard of Care (SOC) in Patients with Resectable, Locally Advanced Head and Neck Squamous Cell Carcinoma

Head and Neck Squamous Cell Carcinoma | Head and Neck Squamous Cell Carcinoma HNSCC

China
Zhejiang Cancer Hospital

Not yet recruiting

A Study to Investigate the Efficacy and Safety of Ivonescimab Combined With Irinotecan Liposome as Second-line Regimen for ES-SCLC

Extensive-stage Small-cell Lung Cancer

China
Peking University Cancer Hospital & Institute

Not yet recruiting

A Trial of AK104 or AK112 in Combination With Axitinib in Patients With Metastatic Mucosal Melanoma

Melanoma | Metastatic Melanoma | Mucosal Melanoma

China
Jiangsu Alphamab Biopharmaceuticals Co., Ltd

Not yet recruiting

Evaluation of JSKN016 Combination Therapy in Subjects with NSCLC

Advanced Non-small Cell Lung Cancer
Wuhan Union Hospital, China

Recruiting

Short-course Radiotherapy Followed by AK112 and CAPOX as Neoadjuvant Therapy for Locally Advanced Rectal Cancer

Neoadjuvant Therapy | Locally Advanced Rectal Cancer

China
Akeso

Not yet recruiting

Ivonescimab in Combination With Docetaxel in Advanced Non-Small Cell Lung Cancer (NSCLC)

Non-Small Cell Lung Cancer
Sichuan University

Recruiting

Phase II Study of Ivonescimab and Cadonilimab in Combination with Chemotherapy in Patients with ES-SCLC

Small Cell Lung Cancer

China
Akeso

Recruiting

Combination Therapy of AK112 With Chemotherapy and/or Olaparib in Platinum-sensitive Ovarian Cancer

Platinum-sensitive Ovarian Cancer

China
Harbin Medical University

Recruiting

AK104 in Combination With AK112 Plus Chemotherapy(SOX/XELOX) as First-line Treatment for Advanced G/GEJ Cancer

Gastric Adenocarcinoma | Gastroesophageal Junction Adenocarcinoma

China
Wuhan Union Hospital, China
Akesobio

Recruiting

Ivonescimab(AK112/SMT112) in Combination With Stereotactic Body Radiation Therapy and Chemotherapy in Patients With Pancreatic Cancer

Pancreatic Cancer

China
Tianjin Medical University Cancer Institute and...

Recruiting

AK112 Combined With Chemotherapy as the First-line Treatment in Advanced Esophageal Squamous Cell Carcinoma Patients

ESCC | Advanced Esophageal Squamous Cell Carcinoma

China
Akeso
Akeso

Active, not recruiting

Phase 3 Clinical Study of AK112 for NSCLC Patients

Non-Squamous Non-small Cell Lung Cancer

China
Sun Yat-sen University
Akeso

Not yet recruiting

A Phase ll Study of Neoadjuvant Short-course Radiotherapy Followed by Ivonescimab and Chemotherapy in pMMR/MSS Locally Advanced Rectal Cancer

Rectal Adenocarcinoma
UNICANCER
Summit Therapeutics

Not yet recruiting

Testing Ivonescimab in Combination With Chemotherapy in Advanced or Metastatic Gastric/Gastroesophageal Adenocarcinoma (GRACIE)

Metastatic Gastric Adenocarcinoma | Advanced Gastric Adenocarcinoma | Metastatic Esophageal Adenocarcinoma | Advanced Esophageal Adenocarcinoma

France

Search clinical trials for: Ivonescimab

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in India

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations